Synthesis, Secretion and Transport of Peptide Hormones

Living reference work entry
Part of the Endocrinology book series (ENDOCR)

Abstract

Peptide hormones are composed of polypeptide chains with a size ranging from three to hundreds of amino acids. Peptide hormone synthesis involves several steps occurring in the nucleus and cytoplasm of secretory cells, including gene transcription into the precursor nuclear ribonucleic acid, posttranscriptional modifications of the precursor messenger ribonucleic acid transcript, translation of the mature messenger ribonucleic acid, and cotranslational and posttranslational modifications of the hormonal peptide. Synthesis of peptide hormones is regulated at one or more of the above-mentioned biosynthetic steps in order to meet the secretory requirements of endocrine glands. Once they are synthesized, peptide hormones are packaged into secretory granules until appropriate stimuli result in their secretion into the extracellular space. Secretion is not uniform, but rather follows pulsatile patterns and rhythmic changes which, in association with feedback mechanisms, ensure that hormone production is adequate and prevent the excessive release of hormones. Most peptide hormones are water soluble and therefore do not require carrier proteins to circulate in the blood stream. This property results in rapid hormone degradation by plasma proteases and a shorter half-life and duration of action compared to other types of hormones, such as steroid and thyroid hormones.

Keywords

Peptide hormone Synthesis Secretion Transport Gene transcription Posttranscriptional processing Translation Posttranslational processing 

References

  1. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 1982;298(5871):240–4.CrossRefPubMedGoogle Scholar
  2. Becker KL. Principles and practice of endocrinology and metabolism. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.Google Scholar
  3. Blundell TL, Humbel RE. Hormone families: pancreatic hormones and homologous growth factors. Nature. 1980;287(5785):781–7.CrossRefPubMedGoogle Scholar
  4. Cooke NE, Coit D, Weiner RI, Baxter JD, Martial JA. Structure of cloned DNA complementary to rat prolactin messenger RNA. J Biol Chem. 1980;255(13):6502–10.PubMedGoogle Scholar
  5. Darnell Jr JE. Variety in the level of gene control in eukaryotic cells. Nature. 1982;297(5865):365–71.CrossRefPubMedGoogle Scholar
  6. Eipper BA, Mains RE. Structure and biosynthesis of pro-adrenocorticotropin/endorphin and related peptides. Endocr Rev. 1980;1:1–27.CrossRefPubMedGoogle Scholar
  7. Fisker S. Physiology and pathophysiology of growth hormone-binding protein: methodological and clinical aspects. Growth Hormon IGF Res. 2006;16(1):1–28.CrossRefGoogle Scholar
  8. Gharib SD, Wierman ME, Shupnik MA, Chin WW. Molecular biology of the pituitary gonadotropins. Endocr Rev. 1990;11(1):177–99.CrossRefPubMedGoogle Scholar
  9. Gibson S, Crosby SR, White A. Discrimination between beta- endorphin and beta-lipotrophin in human plasma using two-site immunoradiometric assays. Clin Endocrinol. 1993;39:445–53.CrossRefGoogle Scholar
  10. Griffin JE, Ojeda SR. Textbook of endocrine physiology. 5th ed. New York: Oxford University Press; 2004.Google Scholar
  11. Jones JI, Clemmons DR. Insulin like growth factor and their binding proteins: biologic actions. Endocr Rev. 1995;16:3–34.PubMedGoogle Scholar
  12. Lodish H, Berk A, Kaiser CA, Krieger M, Scott MP, Bretscher A, et al. Molecular cell biology. 6th ed. New York: W.H. Freeman & Company; 2008.Google Scholar
  13. Molina PE. Endocrine physiology. 4th ed. New York: Mc Graw Hill; 2013.Google Scholar
  14. Normal AW, Litwack G. Hormones. 2nd ed. New York: Academic Press; 1997.Google Scholar
  15. Nussey S, Whitehead S. Endocrinology: an integrated approach. Oxford: BIOS Scientific Publishers; 2001.CrossRefGoogle Scholar
  16. Palazzo AF, Akef A. Nuclear export as a key arbiter of “mRNA identity” in eukaryotes. Biochim Biophys Acta. 2012;1819(6):566–77.CrossRefPubMedGoogle Scholar
  17. Pocock G, Richards CD, Richards D. Human physiology. 4th ed. Oxford: Oxford University Press; 2013.Google Scholar
  18. Pritchard LE, Turnbull AV, White A. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol. 2002;172:411–21.CrossRefPubMedGoogle Scholar
  19. Re R. The nature of intracrine peptide hormone action. Hypertension. 1999;34:534–8.CrossRefPubMedGoogle Scholar
  20. Seasholtz AF, Valverde RA, Denver RJ. Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. J Endocrinol. 2002;175(1):89–97.CrossRefPubMedGoogle Scholar
  21. Veldhuis JD, Keenan DM, Pincus SM. Motivations and methods for analyzing pulsatile hormone secretion. Endocr Rev. 2008;29(7):823–64.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Wintzen M, Yaar M, Burbach JP, Gilchrest BA. Proopiomelanocortin gene product regulation in keratinocytes. J Invest Dermatol. 1996;106:673–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research ProgramNational Institutes of HealthBethesdaUSA
  2. 2.The Warren Alpert School of MedicineBrown UniversityProvidenceUSA

Personalised recommendations